Optimizing Endocrinology Claim Status Tracking with Klivira Automation

The Challenge of Endocrinology Claim Status Management

Endocrinology practices face unique complexities in claim status tracking due to the high volume of prior authorizations for high-cost medications and devices. Treatments like GLP-1 agonists, continuous glucose monitors (CGMs), and insulin pumps often involve intricate payer policies and frequent re-authorization cycles, making manual tracking burdensome. Without automated systems, staff spend excessive time polling payer portals or making phone calls, risking delayed payments and overlooked denials.

Key Prior Authorization Categories Driving Claim Status Needs in Endocrinology

• GLP-1 receptor agonists (e.g., Ozempic, Mounjaro, Zepbound) for T2D and obesity, often with complex step therapy requirements.
• Continuous Glucose Monitoring (CGM) devices (e.g., Dexcom G7, FreeStyle Libre 3/2) requiring periodic re-authorization.
• Insulin pumps and tubeless systems (e.g., Tandem t:slim X2, Omnipod 5), frequently paired with CGMs for hybrid closed-loop systems.
• Growth hormone therapy (e.g., somatropin biosimilars) with specific diagnostic documentation requirements.
• SGLT2 inhibitors (e.g., Jardiance, Farxiga) for T2D, heart failure, and CKD, each with distinct PA criteria.

Automating X12 277 and FHIR ClaimResponse for Endocrinology Claims

Klivira's platform automates the traditionally manual process of claim status inquiry, critical for endocrinology claims. We leverage automated X12 277 polling to proactively retrieve claim statuses from payers, eliminating the need for staff to manually navigate payer portals. For payers adopting modern standards, Klivira integrates with FHIR-based claim flows, consuming ClaimResponse resources via the Da Vinci PAS umbrella, ensuring comprehensive coverage of electronic status updates.

Klivira's End-to-End Claim Status Workflow for Endocrinology

• Automated X12 277 polling on configurable schedules, with aggressive polling for pending/review claims.
• Ingestion of X12 835 remittance advice, matching payments and denials to submitted claims and original prior authorizations.
• Normalization of payer-specific status codes into a uniform claim-state model for consistent visibility.
• Stuck-claim escalation, triggering follow-up workflows for claims pending beyond configurable thresholds.
• Maintained linkage between prior authorization approvals and subsequent claims, surfacing any discrepancies.

Linking Prior Authorization to Claim Adjudication in Endocrinology

A critical capability for endocrinology practices is the seamless linkage between an approved prior authorization and its corresponding claim. Klivira maintains this connection, allowing staff to quickly identify if an authorized service, such as a GLP-1 prescription or an insulin pump, was correctly billed and adjudicated. This prevents situations where an authorized service might be denied at the claim level due to billing errors or discrepancies, a common challenge with complex endocrinology treatments.

Reducing Manual Burden and Mitigating Financial Risk

By automating endocrinology claim status tracking, Klivira significantly reduces the manual polling overhead that burdens revenue cycle teams. Our system proactively identifies stuck claims that might otherwise languish past timely-filing windows, preventing costly write-offs. The normalized status taxonomy and proactive escalation rules ensure that endocrinology claims, particularly for high-value medications and devices, are managed efficiently, safeguarding practice revenue and improving cash flow.